Compositions and methods for recombinational cloning of nucleic acid molecules
AssigneeInvitrogen Corporation
InventorsDevon R.N. Byrd, Dominic Esposito
Life of this patent
Estimating the term…
Loading patent…
AssigneeInvitrogen Corporation
InventorsDevon R.N. Byrd, Dominic Esposito
Estimating the term…
The present invention relates generally to recombinant DNA technology. The invention relates more specifically to compositions and methods for recombinational cloning of nucleic acid molecules using recombination systems. In particular, the invention relates to compositions comprising one or more Fis proteins and one or more additional components used for recombinational cloning (such as one or more recombination proteins). The invention further relates to the use of the above compositions in methods of recombinational cloning of nucleic acid molecules. The invention also relates to isolated nucleic acid molecules produced by methods of the invention, to vectors comprising such nucleic acid molecules, and to host cells comprising such nucleic acid molecules and vectors.
A composition comprising at least one recombination protein and at least one Fis protein or Fis protein fragment, wherein the recombination protein is present in an amount effective for recombinational cloning of at least one nucleic acid molecule and the Fis protein or Fis protein fragment is present in an amount effective for enhancing the efficiency of the recombinational cloning.
A method for enhancing recombinational cloning reactions, the method comprising contacting at least two nucleic acid molecules with at least one Fis protein or Fis protein fragment and at least one recombination protein, wherein the nucleic acid molecules comprise at least one recombination site.
A method for cloning at least one nucleic acid molecule comprising a nucleic acid segment flanked by at least two recombination sites, wherein the recombination sites do not substantially recombine with each other, the method comprising:
A kit for use in recombinational cloning of a nucleic acid molecule, the kit comprising at least one Fis protein or Fis protein fragment.
The kit of claim 78, wherein the E. coli ribosomal protein is L27.
The kit of claim 78, wherein the E. coli ribosomal protein is S15.
Dependencies are inferred from the claim text.